A renal function assessment method includes following steps. A target kidney ultrasound image data of a subject is provided. An image pre-processing step is performed, wherein an image size of the target kidney ultrasound image data is adjusted, and the target kidney ultrasound image data is normalized according to an average and a standard deviation of a visual image database to obtain an after-processed target kidney ultrasound image data. A feature extracting step is performed, wherein the after-processed target kidney ultrasound image data is trained to achieve a convergence by a first deep-learning classifier to obtain an image feature of the after-processed target kidney ultrasound image data. A determining step is performed, wherein the image feature of the after-processed target kidney ultrasound image data is analyzed by the first deep-learning classifier to obtain an assessing result of an estimated glomerular filtration rate (eGFR).

The invention relates to a detection system of an endo-urethral device for an artificial urinary sphincter implantable in the body of a patient, said sphincter comprising an occlusive cuff (2) adapted to compress the urethra, the bladder neck or the prostate of said patient, an activation device (5) of said cuff (2) and a control unit (6) adapted to control the activation device. Said system comprises at least one compression sensor (13) of the urethra and a posture sensor (9), and a processing unit (30) configured to determine: (i) if the compression parameter of the urethra exceeds a predetermined threshold during a predetermined period, (ii) if the patient is in a recumbent position. If the conditions (i) and (ii) are fulfilled, the processing unit sends to the activation device (5) an immediate reduction order of the compression exerted by the cuff (2).

An on-diaper body fluid screening device (100), comprising a stack of the following sheets: a surface sheet (110) permeable to body fluid, a collection sheet (120) impervious to body fluid, a testing sheet (130), which is body fluid absorbent and provided with colorimetric assay reaction pads (131), and which is provided with a body fluid barrier network (132) forming body fluid channels (134) between an inlet section (135) and the colorimetric assay reaction pads (131), a protection sheet (140) impervious to body fluid, and a transparent readout sheet (150), through which the assay reaction pads (131) are visible. The protection sheet (140) comprises pad receiving openings (142). The collection sheet (120) comprises an inlet hole (125) which is arranged over the inlet section (135). A swelling component (702) is arranged in association with the inlet hole (125) and an inlet hole closing member (601).

Systems and methods for assessing a patient's risk of renal dysfunction are described. A system may include sensor circuits to sense physiological signals and processors to generate signal metrics from the physiological signals. The system may generate a primary renal risk indication using a first signal metric, and a secondary renal risk indication using at least a second signal metric. The system may generate a composite renal risk indication and estimate a glomerular filtration rate or a chronic kidney disease stage using at least the primary and secondary risk indications. The composite renal risk indication, which indicative of a degree of renal dysfunction, may be presented to a clinician, or provided to a detector for detecting worsening heart failure.

Technologies for evaluating a user's musculoskeletal health and prescribing treatment plans for the user based on the musculoskeletal health is provided. The disclosed techniques include a computing system receiving input data from a client device. The system formatting the input data to generate one or more sets of user characteristic data values and determining initial levels of user musculoskeletal health for the user based upon the sets of user characteristic data values. The system selects a set of treatment plans for the user based on the initial levels of user musculoskeletal health. The system presents the set of treatment plans to the user using media that allows the user to interactively perform exercises prescribed in the treatment plan.

A method performed by a computer correlates vesicoelastic pressure data (10, 12, 14) with volume data and calculates vesicoelastic work performed by the bladder (20), wherein the amount of vesicoelastic work performed by the bladder (20) is determined by calculating an area under said vesicoelastic pressure data (10, 12, 14) when said vesicoelastic pressure data (10, 12, 14) is correlated against the volume data.

A method performed by a computer correlates vesicoelastic pressure data (10, 12, 14) with volume data and calculates vesicoelastic work performed by the bladder (20), wherein the amount of vesicoelastic work performed by the bladder (20) is determined by calculating an area under said vesicoelastic pressure data (10, 12, 14) when said vesicoelastic pressure data (10, 12, 14) is correlated against the volume data.

Embodiments described herein are directed to an automatic fluid measurement system including a fluid collection system configured to drain a fluid from a patient, and a short wave infrared imaging system configured to image the collection container to provide a high contrast, high resolution image and determine a volume of fluid disposed therein. In an embodiment, the system can determine a fluid flow rate, or determine a presence or concentration of foreign particles within the collection container. One or more cameras can image different portions of the container, or can include different focal lengths. Images of the collection container can be communicated to remote computing devices for further analysis.

Devices and methods are disclosed for determining prostatic urethral length. A balloon catheter subassembly is in fluid communication between an inner cavity of a syringe body and an expandable balloon is positioned at a distal end of the balloon catheter subassembly. An adapter secured to the syringe body having a syringe plunger includes a lock that engages the syringe plunger at a predefined position with respect to the syringe body corresponding to a desired inflation state of the expandable balloon. Prostatic urethral length can then be determined using markings indicating distance from the expandable balloon.

Devices and methods are disclosed for determining prostatic urethral length. A balloon catheter subassembly is in fluid communication between an inner cavity of a syringe body and an expandable balloon is positioned at a distal end of the balloon catheter subassembly. An adapter secured to the syringe body having a syringe plunger includes a lock that engages the syringe plunger at a predefined position with respect to the syringe body corresponding to a desired inflation state of the expandable balloon. Prostatic urethral length can then be determined using markings indicating distance from the expandable balloon.